ASX - By Stock
|
AVR |
Re:
TAVR meeting update
|
|
ashtool
|
24 |
10K |
17 |
19/02/18 |
19/02/18 |
ASX - By Stock
|
24
|
10K
|
17
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
138 |
55K |
8 |
30/01/18 |
30/01/18 |
ASX - By Stock
|
138
|
55K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
138 |
55K |
1 |
30/01/18 |
30/01/18 |
ASX - By Stock
|
138
|
55K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Posh new website!
|
|
ashtool
|
77 |
22K |
0 |
09/01/18 |
09/01/18 |
ASX - By Stock
|
77
|
22K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Posh new website!
|
|
ashtool
|
77 |
22K |
3 |
09/01/18 |
09/01/18 |
ASX - By Stock
|
77
|
22K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Posh new website!
|
|
ashtool
|
77 |
22K |
1 |
08/01/18 |
08/01/18 |
ASX - By Stock
|
77
|
22K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
shareprice
|
|
ashtool
|
3 |
1.6K |
4 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
3
|
1.6K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
shareprice
|
|
ashtool
|
3 |
1.6K |
8 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
3
|
1.6K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Immunotherapy Partner Patrick Soon Shiong
|
|
ashtool
|
24 |
9.0K |
3 |
04/11/17 |
04/11/17 |
ASX - By Stock
|
24
|
9.0K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Wayne Paterson's Email
|
|
ashtool
|
4 |
1.6K |
1 |
01/11/17 |
01/11/17 |
ASX - By Stock
|
4
|
1.6K
|
1
|
|
ASX - By Stock
|
AVR |
Wayne Paterson's Email
|
|
ashtool
|
4 |
1.6K |
4 |
01/11/17 |
01/11/17 |
ASX - By Stock
|
4
|
1.6K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
186 |
54K |
3 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
186
|
54K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
186 |
54K |
0 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
186
|
54K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ahz vax in news
|
|
ashtool
|
21 |
7.6K |
6 |
22/10/17 |
22/10/17 |
ASX - By Stock
|
21
|
7.6K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
BUY BACK IN support this company
|
|
ashtool
|
22 |
9.6K |
4 |
09/08/17 |
09/08/17 |
ASX - By Stock
|
22
|
9.6K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
BUY BACK IN support this company
|
|
ashtool
|
22 |
9.6K |
13 |
09/08/17 |
09/08/17 |
ASX - By Stock
|
22
|
9.6K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Professor Neethling named VP of Cardiovascular Technologies
|
|
ashtool
|
40 |
10K |
6 |
03/08/17 |
03/08/17 |
ASX - By Stock
|
40
|
10K
|
6
|
|
ASX - By Stock
|
AVR |
Dr William Halford of Rational Vaccines (RVx) Dead?
|
|
ashtool
|
1 |
1.5K |
2 |
30/06/17 |
30/06/17 |
ASX - By Stock
|
1
|
1.5K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Releases Results of HSV-2 Phase IIa Study
|
|
ashtool
|
350 |
143K |
1 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
350
|
143K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Receives FDA Clearance for CardioCel 3D
|
|
ashtool
|
134 |
51K |
3 |
02/05/17 |
02/05/17 |
ASX - By Stock
|
134
|
51K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Receives FDA Clearance for CardioCel 3D
|
|
ashtool
|
134 |
51K |
2 |
02/05/17 |
02/05/17 |
ASX - By Stock
|
134
|
51K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
88 |
38K |
2 |
26/04/17 |
26/04/17 |
ASX - By Stock
|
88
|
38K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
88 |
38K |
1 |
26/04/17 |
26/04/17 |
ASX - By Stock
|
88
|
38K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
88 |
38K |
0 |
26/04/17 |
26/04/17 |
ASX - By Stock
|
88
|
38K
|
0
|
|
ASX - By Stock
|
AVR |
TAVR on News
|
|
ashtool
|
1 |
1.0K |
3 |
11/04/17 |
11/04/17 |
ASX - By Stock
|
1
|
1.0K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
hsv2 final results
|
|
ashtool
|
99 |
39K |
2 |
06/04/17 |
06/04/17 |
ASX - By Stock
|
99
|
39K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
hsv2 final results
|
|
ashtool
|
99 |
39K |
0 |
03/04/17 |
03/04/17 |
ASX - By Stock
|
99
|
39K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AHZ Shareholder Survey
|
|
ashtool
|
24 |
7.3K |
2 |
23/03/17 |
23/03/17 |
ASX - By Stock
|
24
|
7.3K
|
2
|
|
ASX - By Stock
|
AVR |
Immunotherapy is the future of cancer treatment.
|
|
ashtool
|
2 |
1.1K |
5 |
20/03/17 |
20/03/17 |
ASX - By Stock
|
2
|
1.1K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Appoints Wayne Paterson as CEO
|
|
ashtool
|
121 |
46K |
1 |
15/03/17 |
15/03/17 |
ASX - By Stock
|
121
|
46K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Appoints Wayne Paterson as CEO
|
|
ashtool
|
121 |
46K |
14 |
15/03/17 |
15/03/17 |
ASX - By Stock
|
121
|
46K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Appoints John Seaberg as Chairman
|
|
ashtool
|
38 |
12K |
0 |
14/03/17 |
14/03/17 |
ASX - By Stock
|
38
|
12K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Appoints John Seaberg as Chairman
|
|
ashtool
|
38 |
12K |
2 |
14/03/17 |
14/03/17 |
ASX - By Stock
|
38
|
12K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Appoints John Seaberg as Chairman
|
|
ashtool
|
38 |
12K |
3 |
14/03/17 |
14/03/17 |
ASX - By Stock
|
38
|
12K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Appoints John Seaberg as Chairman
|
|
ashtool
|
38 |
12K |
5 |
14/03/17 |
14/03/17 |
ASX - By Stock
|
38
|
12K
|
5
|
|
ASX - By Stock
|
RHC |
Why is this stock trending down?
|
|
ashtool
|
15 |
9.6K |
1 |
13/03/17 |
13/03/17 |
ASX - By Stock
|
15
|
9.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Patersons Research - BUY
|
|
ashtool
|
164 |
60K |
1 |
09/03/17 |
09/03/17 |
ASX - By Stock
|
164
|
60K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Patersons Research - BUY
|
|
ashtool
|
164 |
60K |
7 |
08/03/17 |
08/03/17 |
ASX - By Stock
|
164
|
60K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
ashtool
|
1.2K |
445K |
3 |
05/03/17 |
05/03/17 |
ASX - By Stock
|
1.2K
|
445K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Updated Top 20
|
|
ashtool
|
24 |
11K |
0 |
03/03/17 |
03/03/17 |
ASX - By Stock
|
24
|
11K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Shareholder Webinar
|
|
ashtool
|
233 |
75K |
5 |
28/02/17 |
28/02/17 |
ASX - By Stock
|
233
|
75K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Shareholder Webinar
|
|
ashtool
|
233 |
75K |
2 |
28/02/17 |
28/02/17 |
ASX - By Stock
|
233
|
75K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Shareholder Webinar
|
|
ashtool
|
233 |
75K |
2 |
28/02/17 |
28/02/17 |
ASX - By Stock
|
233
|
75K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Shareholder Webinar
|
|
ashtool
|
233 |
75K |
5 |
28/02/17 |
28/02/17 |
ASX - By Stock
|
233
|
75K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Shareholder Webinar
|
|
ashtool
|
233 |
75K |
1 |
28/02/17 |
28/02/17 |
ASX - By Stock
|
233
|
75K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
ashtool
|
1.2K |
445K |
8 |
27/02/17 |
27/02/17 |
ASX - By Stock
|
1.2K
|
445K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
ashtool
|
1.2K |
445K |
4 |
27/02/17 |
27/02/17 |
ASX - By Stock
|
1.2K
|
445K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
ashtool
|
1.2K |
445K |
0 |
27/02/17 |
27/02/17 |
ASX - By Stock
|
1.2K
|
445K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
ashtool
|
1.2K |
445K |
7 |
27/02/17 |
27/02/17 |
ASX - By Stock
|
1.2K
|
445K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
1 |
27/02/17 |
27/02/17 |
ASX - By Stock
|
210
|
68K
|
1
|
|